Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound

Study summary

The purpose of this study is to assess if there is decrease in cough during flexible bronchoscopy and endobronchial ultrasound when different modes of lidocaine administration are used. The modes of administration being evaluated are topical, nebulized and atomized.

Ask AI to explain this study

Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedTopical lidocaine and Nebuliser solution

Plus 1 other study approaches.

Who it may be forBronchiectasis Adult · Mediastinal Lymphadenopathy

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Oct 12, 2021 · Source: ClinicalTrials.gov

Is enrollment open?Terminated

Ask the study team to confirm whether enrollment is open.

What kind of study?Phase 3

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Milton S. Hershey Medical Center

Study sponsor

Study overview

What this study is about

Purpose: Treatment
Study type: Interventional
Phase: Phase 3
Sponsor: Milton S. Hershey Medical Center
Interventions being studied: Drug: Topical lidocaine; Drug: Nebuliser solution; Drug: Nebuliser Suspension

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Diagnosis of mediastinal and/or hilar lymphadenopathy requiring endobronchial ultrasound evaluation and transbronchial needle aspiration.
Diagnosis of pulmonary disease requiring flexible bronchoscopy
Greater than 18 years of age.

Reasons someone may not be able to joinExclusion criteria

Any intervention beyond flexible bronchoscopy and endobronchial ultrasound
Inability to tolerate bronchoscopy.
Patients that receive paralytics.
Patients with neuromuscular diseases.
Inability to consent for procedures.
Allergies to lidocaine or any other drugs used in protocol.
Existing renal insufficiency or liver disease

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Penn State Hershey Medical CenterHershey, Pennsylvania

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Oct 12, 2021. Always confirm current availability with the study team.

View original record ↗